KSHB: Saint Luke's Leads Groundbreaking AFib Treatment
Atrial Fibrillation, or Afib, is the most common type of heart arrhythmia and the number of people diagnosed with AFib is increasing both in the United States and globally.
Saint Luke’s Mid America Heart Institute cardiologists were the first in Kansas and Missouri to participate in a clinical trial for a novel treatment of AFib known as "pulsed field ablation."
Dr. Sanjaya Gupta spoke to KSHB about this groundbreaking treatment, as well as the second Saint Luke's patient to undergo pulsed field ablation.
Watch the full KSHB story: Saint Luke’s Helps Lead Groundbreaking Clinical Trial for Afib Treatment.
Relevant News
News
Three Saint Luke's Physicians Named Ingram’s Top Doctors of 2026
News
Healthy Kansas City: Back on Track: Getting to the Bottom of Your Low Back Pain
News
KOMU: Breast Cancer Awareness Goes Beyond Early Detection for Missouri Woman Living With Advanced Cancer
News
FOX 4: Water Shut Off at Riverside Senior Facility Amid Legionnaires’ Disease Investigation
News
Health News You Can Use: Saint Luke’s Koontz Center for Advanced Breast Cancer’s 10th Anniversary
News